
Bruker Corp Boosts Revenue 13.6% to $3.4B Through Key Acquisitions
Bruker CorporationDescription
What this story covers
Bruker Corporation's 2024 10-K shows 13.6% revenue growth to $3.4 billion, driven by acquisitions like ELITechGroup and NanoString, enhancing diagnostics and spatial biology. Despite margin pressures and higher expenses, strategic investments fueled expansion. Liquidity remains solid amid $2.1 billion debt.
Story snapshot
CompanyBruker Corporation
TickerBRKR
VariantStandard detailed
Duration13:41
Filing type10-K
PeriodAnnual 2024
IndustryTechnology
Accession0000950170-25-030897
Full Story Script
Content not available for this story.